ストックスクリーナーアプリを入手
2.33
9.91%
0.21
アフターアワーズ：
2.34
0.010
+0.43%
前日終値:
$2.12
開ける：
$2.08
24時間の取引高:
400.45K
Relative Volume:
1.02
時価総額：
$141.14M
収益：
-
当期純損益:
$-64.86M
株価収益率:
-2.0804
EPS:
-1.12
ネットキャッシュフロー:
$-55.66M
1週間 パフォーマンス:
+23.94%
1か月 パフォーマンス:
+76.52%
6か月 パフォーマンス:
+111.82%
1年 パフォーマンス:
-0.85%
1日の値動き範囲:
$2.01
$2.35
1週間の範囲:
$1.86
$2.35
52週間の値動き範囲:
$0.8551
$3.36
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
名前
Acumen Pharmaceuticals Inc
セクター
電話
617-344-4190
住所
1210-1220 WASHINGTON STREET, NEWTON
ABOS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals Inc
|
2.33 | 128.42M | 0 | -64.86M | -55.66M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-17 | 開始されました | Citigroup | Buy |
| 2024-07-26 | 開始されました | Citigroup | Buy |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2023-07-20 | 再開されました | BofA Securities | Buy |
| 2023-05-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-07-15 | 開始されました | BTIG Research | Buy |
| 2022-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-21 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-07-26 | 開始されました | BofA Securities | Neutral |
| 2021-07-26 | 開始されました | Credit Suisse | Outperform |
| 2021-07-26 | 開始されました | Stifel | Buy |
| 2021-07-26 | 開始されました | UBS | Buy |
すべてを表示
Acumen Pharmaceuticals Inc (ABOS) 最新ニュース
Long term hold vs stop loss in Acumen Pharmaceuticals Inc.2025 Earnings Surprises & AI Driven Price Predictions - newser.com
Relative strength of Acumen Pharmaceuticals Inc. in sector analysisJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Tools to monitor Acumen Pharmaceuticals Inc. recovery probabilityJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Acumen Pharmaceuticals Inc. stock retracement – recovery analysisTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
What to do if you’re stuck in Acumen Pharmaceuticals Inc.2025 Price Momentum & Target Return Focused Stock Picks - newser.com
What the charts say about Acumen Pharmaceuticals Inc. todayQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Is Acumen Pharmaceuticals Inc. stock a top pick in earnings season2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
How Acumen Pharmaceuticals Inc. stock reacts to oil prices2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Central Nervous System Biomarkers Market Growth & Industry - openPR.com
What analysts say about Acumen Pharmaceuticals Inc stockMomentum Trading Signals & Stay One Step Ahead of Risk Events - earlytimes.in
Institutional scanner results for Acumen Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Entry Signals - newser.com
Trend analysis for Acumen Pharmaceuticals Inc. this weekWeekly Profit Recap & AI Driven Price Forecasts - newser.com
Published on: 2025-10-05 05:00:14 - newser.com
Will Acumen Pharmaceuticals Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - newser.com
Is it time to cut losses on Acumen Pharmaceuticals Inc.July 2025 Trends & Verified Momentum Watchlists - newser.com
Promising Penny Stocks To Watch In September 2025 - Yahoo Finance
Analyzing net buyer seller activity in Acumen Pharmaceuticals Inc.July 2025 Setups & AI Powered Market Entry Ideas - newser.com
Is Acumen Pharmaceuticals Inc a good long term investmentHigh Dividend Yield Stocks & Outstanding Capital Tips - earlytimes.in
Acumen Pharmaceuticals, Inc. $ABOS Shares Sold by Goldman Sachs Group Inc. - Defense World
Acumen Pharmaceuticals Inc (ABOS) 財務データ
収益
当期純利益
現金流量
EPS
Acumen Pharmaceuticals Inc (ABOS) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zuga Matt | CFO & Chief Business Officer |
Jan 21 '25 |
Sale |
1.60 |
4,364 |
6,986 |
260,646 |
| OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '25 |
Sale |
1.59 |
12,619 |
20,102 |
667,488 |
| Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '25 |
Sale |
1.59 |
3,418 |
5,435 |
161,127 |
| Barton Russell | Chief Operating Officer |
Jan 21 '25 |
Sale |
1.61 |
2,914 |
4,692 |
136,117 |
| Siemers Eric | Chief Medical Officer |
Jan 21 '25 |
Sale |
1.59 |
3,219 |
5,118 |
170,298 |
5.15%
1.45%
大文字化:
|
ボリューム (24 時間):